Redeye: BONESUPPORT Q4 - Sales estimates beat again

2023-02-16 17:23:00

Redeye returns with a more in-depth take on BONESUPPORT’s Q4 report, rendering some changes to our financial estimates. We are encouraged by the US CERAMENT G sales in the quarter and up our estimates for this product in the US for 2023e. Moreover, we increase our fair value range considerably.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.